Since evidence shows anti-estrogen drugs will fail in a many patients with estrogen-receptor-positive breast cancer,says Knudsen, our research suggests that physicians should examine both estrogen receptor status and RB tumor suppressor status during the
Since evidence shows anti-estrogen drugs will fail in a many patients with estrogen-receptor-positive breast cancer,says Knudsen, our research suggests that physicians should examine both estrogen receptor status and RB tumor suppressor status during the
证据表明，抗雌激素药物对雌激素受体阳性乳癌将失效，我们的研究提示，为了给那些特殊癌症患者制定最有效的治疗方法，医生应该在开始诊断时检测雌激素受体和RB抑癌基因状况。